Spots Global Cancer Trial Database for sarcoma, kaposi
Every month we try and update this database with for sarcoma, kaposi cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma | NCT00923936 | Sarcoma, Kaposi | Liposomal Doxor... Bevacizumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma | NCT00002131 | Sarcoma, Kaposi HIV Infections | Vesnarinone | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00000987 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma | NCT00923936 | Sarcoma, Kaposi | Liposomal Doxor... Bevacizumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy | NCT00000807 | Sarcoma, Kaposi HIV Infections | Etoposide | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | NCT00000660 | Sarcoma, Kaposi HIV Infections | Etoposide | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. | NCT00002147 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies | NCT00051597 | Hodgkin Disease Lymphoma, Large... Sarcoma, Kaposi Lymphoma, T-Cel... Lymphoma, B-Cel... | SGN-30 (monoclo... | 18 Years - | Seagen Inc. | |
| A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | NCT00002136 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma | NCT00000994 | HIV Infections | Zidovudine | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma | NCT00001113 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Interferon alfa... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients | NCT00002445 | Sarcoma, Kaposi HIV Infections | IM862 | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma | NCT00000725 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Interferon alfa... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | NCT00002093 | Sarcoma, Kaposi HIV Infections | Daunorubicin (l... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma | NCT00002318 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma | NCT00002226 | Sarcoma, Kaposi HIV Infections | SU5416 | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma | NCT00000769 | Sarcoma, Kaposi HIV Infections | Interleukin-4 | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 | NCT00002137 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma | NCT00002259 | Sarcoma, Kaposi HIV Infections | Mitoxantrone hy... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma | NCT00000763 | Sarcoma, Kaposi HIV Infections | TNP-470 | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment | NCT00005931 | Sarcoma, Kaposi HIV Infections | SU5416 | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Study of Patients With AIDS Syndrome | NCT00001120 | Sarcoma, Kaposi Lymphoma, Non-H... HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | ||
| Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals | NCT00002189 | Sarcoma, Kaposi HIV Infections | Paclitaxel | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma | NCT00002226 | Sarcoma, Kaposi HIV Infections | SU5416 | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 | NCT00002185 | Sarcoma, Kaposi HIV Infections | Nelfinavir mesy... | 13 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma | NCT00000769 | Sarcoma, Kaposi HIV Infections | Interleukin-4 | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma | NCT00002262 | Sarcoma, Kaposi HIV Infections | Tumor Necrosis ... | 18 Years - 70 Years | NIH AIDS Clinical Trials Information Service | |
| Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals | NCT00002189 | Sarcoma, Kaposi HIV Infections | Paclitaxel | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 | NCT00002137 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | NCT00002138 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma | NCT00002366 | Sarcoma, Kaposi HIV Infections | Ritonavir | 18 Years - | Abbott | |
| A Study of Tecogalan Sodium | NCT00002342 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. | NCT00002167 | Sarcoma, Kaposi HIV Infections | Tin ethyl etiop... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. | NCT00002167 | Sarcoma, Kaposi HIV Infections | Tin ethyl etiop... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma | NCT00000687 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | NCT00002138 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | NCT00002093 | Sarcoma, Kaposi HIV Infections | Daunorubicin (l... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | NCT00002136 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00001059 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Filgrastim Bleomycin sulfa... Vincristine sul... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | NCT00002138 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Tecogalan Sodium | NCT00002342 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma | NCT00002188 | Sarcoma, Kaposi HIV Infections | Alitretinoin | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma | NCT00000694 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Sargramostim | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma | NCT00002105 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Bleomycin sulfa... Vincristine sul... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| KSHV Infection in Blood Donors From Texas | NCT00006310 | Blood Donors Acquired Immuno... Blood Transfusi... Herpesvirus, Ka... Sarcoma, Kaposi HIV Infections | - 100 Years | The University of Texas Health Science Center at San Antonio | ||
| Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders | NCT00002153 | Sarcoma, Kaposi HIV Infections Lymphoprolifera... | A-007 | 21 Years - | NIH AIDS Clinical Trials Information Service | |
| A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma | NCT00001113 | Sarcoma, Kaposi HIV Infections | Interferon alfa... Zidovudine Interferon alfa... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
